These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 25760967)
1. Tumor chemosensitization by physical exercise? Insights from an anidmal model. Vaccarezza M; Vitale M Future Oncol; 2015; 11(6):885-7. PubMed ID: 25760967 [No Abstract] [Full Text] [Related]
2. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1. Gillet JP; Gottesman MM Drug Resist Updat; 2012; 15(1-2):2-4. PubMed ID: 22465109 [No Abstract] [Full Text] [Related]
3. [Resistance to cytostatic drugs]. Elonen E Duodecim; 1998; 114(13):1319-28. PubMed ID: 11552258 [No Abstract] [Full Text] [Related]
4. Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment. Kostanová-Poliaková D; Sabová L Neoplasma; 2005; 52(6):441-9. PubMed ID: 16284687 [TBL] [Abstract][Full Text] [Related]
5. [Role of endogenous iron in tumor sensitization to antitumor therapy]. Chekhun VF; Shpilevaia SI Vopr Onkol; 2010; 56(3):251-61. PubMed ID: 20804045 [No Abstract] [Full Text] [Related]
6. Achilles heels and Trojan horses against drug-resistant tumor cells. Park K J Control Release; 2011 Jan; 149(2):91. PubMed ID: 21167115 [No Abstract] [Full Text] [Related]
7. Chemosensitization of solid tumors by modulation of resistance mechanisms. Cree IA; Knight L; Di Nicolantonio F; Sharma S; Gulliford T Curr Opin Investig Drugs; 2002 Apr; 3(4):634-40. PubMed ID: 12090736 [TBL] [Abstract][Full Text] [Related]
8. Cancer and natural selection. Fillon M J Natl Cancer Inst; 2012 Dec; 104(23):1773-4. PubMed ID: 23213180 [No Abstract] [Full Text] [Related]
9. The search for optimal response prediction in cancer leads to a personalized approach. Van Cutsem E; Ciardiello F Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283 [No Abstract] [Full Text] [Related]
10. Targeted agents: the rules of combination. Kwak EL; Clark JW; Chabner B Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5232-7. PubMed ID: 17875749 [TBL] [Abstract][Full Text] [Related]
16. The roadmap of TRAIL apoptotic pathway-targeted cancer therapies: What is next? Bellail AC; Hao C Expert Rev Anticancer Ther; 2012 May; 12(5):547-9. PubMed ID: 22594889 [No Abstract] [Full Text] [Related]
17. Clinical relevance of P-glycoprotein with respect to the application of resistance modifiers. Scheulen ME Int J Clin Pharmacol Ther; 1998 Jan; 36(1):41-5. PubMed ID: 9476147 [No Abstract] [Full Text] [Related]
18. New targets for cancer chemotherapy. Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208 [No Abstract] [Full Text] [Related]
19. [The inhibition of apoptosis in cancer cells resistant to anticancer drugs]. Nowak R; Tarasiuk J Postepy Biochem; 2004; 50(4):330-43. PubMed ID: 15957528 [No Abstract] [Full Text] [Related]
20. [Advances in studies on inhibitor of apoptosis proteins and cancer therapy]. Wang XH; Fu LW Yao Xue Xue Bao; 2006 Feb; 41(2):103-7. PubMed ID: 16671537 [No Abstract] [Full Text] [Related] [Next] [New Search]